Showing results (41-50 of 132) with videos related to
Sort By:
Pageof 14
Nutricion Hospitalaria|March 1, 2017
Underfeeding versus full enteral feeding in critically ill patients with acute respiratory failure: a systematic review with meta-analysis of randomized controlled trialsOellen Stuani Franzosi, Anize Delfino von Frankenberg, Sergio Henrique Loss, et al.Nanoscale|December 11, 2012
Synthesis and characterization of designed BMHP1-derived self-assembling peptides for tissue engineering applicationsDiego Silva, Antonino Natalello, Babak Sanii, et al.Clinical and Translational Science|February 1, 2020
Open Data Revolution in Clinical Research: Opportunities and ChallengesMohamed H Shahin, Sanchita Bhattacharya, Diego Silva, et al.Nursing Reports (Pavia, Italy)|March 26, 2025
Socially Responsible Behaviors of Nursing Students in Private Universities in Santiago, Chile: A Study on the Alignment with Sustainable Development GoalsSandra Vera-Ruiz, Alejandro Vega-Muñoz, Nicolás Contreras-Barraza, et al.Revista Brasileira De Terapia Intensiva|April 27, 2017
Chronic critical illness: are we saving patients or creating victims?Sergio Henrique Loss, Diego Silva Leite Nunes, Oellen Stuani Franzosi, et al.Neuroimage. Clinical|July 15, 2017
Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosisMichael G Dwyer, Diego Silva, Niels Bergsland, et al.Multiple Sclerosis and Related Disorders|April 21, 2023
Therapy effect on AI-derived thalamic atrophy using clinical routine MRI protocol: A longitudinal, multi-center, propensity-matched multiple sclerosis studyDejan Jakimovski, Diego Silva, Niels Bergsland, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 25, 2020
Comparison of first-line and second-line use of fingolimod in relapsing MS: The open-label EARLIMS studyOscar Fernández, Guillermo Izquierdo, Eduardo Aguera, et al.Neuroimage. Clinical|December 3, 2020
Age-dependent cut-offs for pathological deep gray matter and thalamic volume loss using Jacobian integrationRoland Opfer, Julia Krüger, Lothar Spies, et al.CNS Drugs|December 23, 2017
Assessing 'No Evidence of Disease Activity' Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) StudyBianca Weinstock-Guttman, Jennie Medin, Nasreen Khan, et al.Pageof 14